Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147
- Citation:
- Clin Colorectal Cancer vol 13 (2) 100-109
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Other
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 576
- Children:
- None
- Pharmas:
- Grants:
- CA37377, CA-37404, N01 CA032102, U10 CA077202, CA077202, U10 CA021115, U10 CA012027, U10 CA180835, CA12027, U10 CA031946, CA-14028, U10 CA037404, U24 CA114740, U10 CA014028, CA-114740, CA-35103, CA-25224, U10 CA180850, U10 CA037403, U10 CA035272, CA49957, CA-35113, CA-32102, U10 CA032102, U10 CA035113, U10 CA180790, P30 CA015083, P30 CA016058, U10 CA180820, CA-35272, U10 CA049957, CA21115, U10 CA025224, U10 CA180888, CA31946, U10 CA037377, U10 CA035103
- Corr. Author:
- Authors:
- Jocelin Huang Suresh G. Nair Michelle R. Mahoney Garth D. Nelson Anthony F. Shields Emily Chan Richard M. Goldberg Sharlene Gill Morton S. Kahlenberg James T. Quesenberry Stephen N. Thibodeau Thomas C. Smyrk Axel Grothey Frank A. Sinicrope Thomas A. Webb Gist H. Farr Barbara A. Pockaj Jeffrey L. Berenberg Margaret Mooney Daniel J. Sargent Steven R. Alberts
- Networks:
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adjuvant therapy, Disease free survival, Overall survival, Response rate